Terms: = Endocrine gland cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346
150 results:
1. Mesonephric-like adenocarcinoma of the ovary.
Yang Y; Zhao M; Jia Q; Tang H; Xing T; Li Y; Tang B; Xu L; Wei W; Zheng H; Shi R; Xia B; Chen J
J Ovarian Res; 2024 Mar; 17(1):57. PubMed ID: 38444000
[TBL] [Abstract] [Full Text] [Related]
2. Invasive micropapillary carcinoma of the breast and bilateral ovarian mature cystic teratoma with benign Brenner tumor in a postmenopausal woman - An uncommon occurrence.
Ayyanar P; Mitra S; Imaduddin M; Muduly DK
Indian J Pathol Microbiol; 2024; 67(1):189-191. PubMed ID: 38358219
[TBL] [Abstract] [Full Text] [Related]
3. Recurrent gata3 P409Afs*99 Frameshift Extension Mutations in Sweat-gland Carcinoma With Neuroendocrine Differentiation.
Goto K; Kiniwa Y; Kukita Y; Ohe S; Hiraki T; Hishima T; Takai T; Honma K
Am J Surg Pathol; 2024 May; 48(5):528-537. PubMed ID: 38353459
[TBL] [Abstract] [Full Text] [Related]
4. Fine needle aspiration biopsy of parathyroid; is it meaningful? A cytologic study of 81 cases with histological and clinical correlations.
Bakuła-Zalewska E; Długosińska J; Stanek-Widera A; Góralski P; Gałczyński J; Żyłka A; Durzyńska M; Dedecjus M
Cytopathology; 2024 May; 35(3):362-370. PubMed ID: 38213192
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of gata3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation.
Ricci C; Ambrosi F; Grillini A; Massari F; Fiorentino M; Colecchia M; Ulbright TM; Acosta AM
Virchows Arch; 2024 Apr; 484(4):709-713. PubMed ID: 38141134
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
Xiong Y; Kong X; Mei H; Wang J; Zhou S
Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
[TBL] [Abstract] [Full Text] [Related]
7. Liver Mass as First-Time Diagnosis of Sarcomatoid Anaplastic Thyroid Carcinoma: A Rare Malignancy Presenting at an Unexpected Body Site.
Kamashki A; Rivera M; Sturgis CD
Am J Case Rep; 2023 Dec; 24():e941838. PubMed ID: 38041397
[TBL] [Abstract] [Full Text] [Related]
8. Differences in invasiveness and recurrence rate among nonfunctioning pituitary neuroendocrine tumors depending on tumor subtype.
Taguchi A; Kinoshita Y; Amatya VJ; Onishi S; Go Y; Tominaga A; Takeshima Y; Yamasaki F; Horie N
Neurosurg Rev; 2023 Nov; 46(1):317. PubMed ID: 38030890
[TBL] [Abstract] [Full Text] [Related]
9. Divergent Lineage Markers in Anaplastic Thyroid Carcinoma.
Mneimneh WS; Asa SL
Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
[TBL] [Abstract] [Full Text] [Related]
10. Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumors.
Abdel-Salam GMH; Hellmuth S; Gradhand E; Käseberg S; Winter J; Pabst AS; Eid MM; Thiele H; Nürnberg P; Budde BS; Toliat MR; Brecht IB; Schroeder C; Gschwind A; Ossowski S; Häuser F; Rossmann H; Abdel-Hamid MS; Hegazy I; Mohamed AG; Schneider DT; Bertoli-Avella A; Bauer P; Pearring JN; Pfundt R; Hoischen A; Gilissen C; Strand D; Zechner U; Tashkandi SA; Faqeih EA; Stemmann O; Strand S; Bolz HJ
JCI Insight; 2023 Nov; 8(22):. PubMed ID: 37796616
[TBL] [Abstract] [Full Text] [Related]
11. HepPar1 and GATA-3 Expression in Neuroendocrine Neoplasms: A Potential Trap for Pathologic Diagnosis.
Xu L; Yu G; Jiang L; Song X; Qu G; Luo J; Cai L
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):668-672. PubMed ID: 37751245
[TBL] [Abstract] [Full Text] [Related]
12. High-Dose Rate Brachytherapy Combined with PD-1 Blockade as a Treatment for Metastatic Adrenocortical Carcinoma - A Single Center Case Series.
Schwarzlmueller P; Corradini S; Seidensticker M; Zimmermann P; Schreiner J; Maier T; Triebig A; Knösel T; Pazos M; Pfluger T; Weigand I; Belka C; Ricke J; Reincke M; Schmidmaier R; Kroiss M
Horm Metab Res; 2024 Jan; 56(1):30-37. PubMed ID: 37748508
[TBL] [Abstract] [Full Text] [Related]
13. DNA repair function scores for 2172 variants in the BRCA1 amino-terminus.
Diabate M; Islam MM; Nagy G; Banerjee T; Dhar S; Smith N; Adamovich AI; Starita LM; Parvin JD
PLoS Genet; 2023 Aug; 19(8):e1010739. PubMed ID: 37578980
[TBL] [Abstract] [Full Text] [Related]
14. [WHO Histological Classification of Pituitary Tumors].
Nishioka H
No Shinkei Geka; 2023 Jul; 51(4):642-653. PubMed ID: 37491061
[TBL] [Abstract] [Full Text] [Related]
15. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
16. PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/gata3 axis.
Wang H; Zhou Y; Zhang S; Qi YA; Wang M
Oncol Res; 2021; 29(4):275-289. PubMed ID: 37303939
[TBL] [Abstract] [Full Text] [Related]
17. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
Asa SL; Mete O; Riddle ND; Perry A
Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
[TBL] [Abstract] [Full Text] [Related]
18. Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C.
Hu C; Nagaraj AB; Shimelis H; Montalban G; Lee KY; Huang H; Lumby CA; Na J; Susswein LR; Roberts ME; Marshall ML; Hiraki S; LaDuca H; Chao E; Yussuf A; Pesaran T; Neuhausen SL; Haiman CA; Kraft P; Lindstrom S; Palmer JR; Teras LR; Vachon CM; Yao S; Ong I; Nathanson KL; Weitzel JN; Boddicker N; Gnanaolivu R; Polley EC; Mer G; Cui G; Karam R; Richardson ME; Domchek SM; Yadav S; Hruska KS; Dolinsky J; Weroha SJ; Hart SN; Simard J; Masson JY; Pang YP; Couch FJ
Cancer Res; 2023 Aug; 83(15):2557-2571. PubMed ID: 37253112
[TBL] [Abstract] [Full Text] [Related]
19. An Attempt to Stretch the Benefit: Rechallenge with PARP Inhibitors in Ovarian cancer.
Gonzalez-Ochoa E; Oza AM
Clin Cancer Res; 2023 Jul; 29(14):2563-2566. PubMed ID: 37191665
[TBL] [Abstract] [Full Text] [Related]
20. High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
Travaglino A; Santoro A; Arciuolo D; Raffone A; Scaglione G; D'Alessandris N; Valente M; Sfregola S; Fulgione C; Onori ME; Minucci A; Zannoni GF
Virchows Arch; 2023 Dec; 483(6):879-883. PubMed ID: 37166561
[TBL] [Abstract] [Full Text] [Related]
[Next]
